Xiaohua H. Ying
NHC Key Laboratory Of Health Technology Assessment, Key Laboratory Of Public Health Safety
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Adult and maternal pertussis vaccination in China: intention, preferences, and pricing implications from a discrete choice experiment.
Journal: Vaccine
Published: September 23, 2025
The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer.
Journal: Frontiers in public health
Published: February 06, 2025
Corrigendum to "The pilot of a new patient classification-based payment system in China: The impact on costs, length of stay and quality" [Soc. Sci. Med. Volume 289, November 2021, 114415].
Journal: Social science & medicine (1982)
Published: January 30, 2025
From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.
Journal: Human vaccines & immunotherapeutics
Published: August 22, 2024
The Impact of a New Case-Based Payment System on Quality of Care: A Difference-in-Differences Analysis in China.
Journal: Risk management and healthcare policy
Published: July 26, 2024
Provincial inequality of China's progress towards universal health coverage: An empirical analysis in 2016-21.
Journal: Journal of global health
Published: June 28, 2024
Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study.
Journal: International journal of health policy and management
Published: February 18, 2024
Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World.
Journal: International journal of health policy and management
Published: September 22, 2023
Hospital response to a new case-based payment system in China: the patient selection effect.
Journal: Health policy and planning
Published: September 14, 2023
Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases.
Journal: International journal of health policy and management
Published: January 01, 2023
Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence.
Journal: International journal of health policy and management
Published: January 01, 2023
A guideline for economic evaluations of vaccines and immunization programs in China.
Journal: Human vaccines & immunotherapeutics
Published: October 26, 2022
Last Updated: 09/26/2026